معرفی
Scott Edwards is a Senior Lecturer in Veterinary Pharmacology at Charles Sturt University, working within the School of Agricultural, Environmental and Veterinary Sciences. He holds a BSc, BVMS, and PhD, and is a member of the Australian College of Veterinary Scientists (MACVSc). Dr. Edwards graduated as a Veterinary Surgeon from Murdoch University in 1988, worked in pig consultancy and small animal practice in Australia and the UK, returned to Murdoch University in 2002 as a lecturer in pharmacology, attained his PhD in 2008, and moved to Charles Sturt University in 2009.
Dr. Edwards' research focuses on veterinary pharmacology with key areas including:
- Sustained/controlled drug delivery platforms for intra-articular administration of NSAIDs
- Alginate gel platforms for drug delivery into the eye and peritoneal cavity
- Pharmacokinetics of drugs in horses and other animals
- Potential therapeutics for perennial ryegrass staggers in sheep
- Stress management in livestock
- Multi-modal analgesia in small animals
His recent work demonstrates a clear evolution toward cannabinoid pharmacology in livestock, with multiple 2024 publications examining CBD and THC in sheep, alongside evaluation of industrial hemp as livestock feed. Earlier research prominently features pergolide pharmacokinetics in horses (for treating pituitary pars intermedia dysfunction), bromide therapy for ryegrass staggers in sheep, and caffeine effects on lamb survival. His publication record shows consistent research activity from 2007 to 2024 with over 30 documented research outputs.
Notable scientific achievements include:
- Multiple patents related to stress management in livestock and treatment of toxicoses
- Development of models for investigating perennial ryegrass toxicosis in sheep
- Chapter editor for NSAIDs section in Merck Veterinary Manual (2014)
Dr. Edwards maintains clinical relevance through one day per week in small animal clinics, which he describes as keeping him 'in touch with the real veterinary world.' His research has generated significant impact, particularly in stress management and toxicosis treatment, with commercialization of patent IP underway. He has an h-index of 10 according to Scopus, with 401 citations, and has served as principal supervisor for HDR students on projects related to perennial ryegrass toxicosis.
